Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 May 2022
An image of Dr Jerry Mofokeng wa Makhetha’s book, I am a Man

The University of the Free State (UFS) Sasol Library, in collaboration with the Office for International Affairs, invites you to the launch of a book by Dr Jerry Mofokeng wa Makhetha, titled I am a man.  In this book, he explains his complex relationship with masculinity, fatherhood, and identity. 

Date: 18 May 2022
Time: 17:00-18:30
Venue: UFS Sasol Library – Level 2

About the author

Dr Jerry Mofokeng
On 28 June 2019, Dr Jerry Mofokeng wa Makhetha received an honorary Doctor of Letters (DLitt) degree from the University of the Free State (UFS) for his commitment to scholarship and his service to humanity.

Dr Makhetha is an iconic and award-winning South African actor who has appeared in several critically acclaimed films, including Cry, the Beloved Country; Lord of War; Mandela and de Klerk; and the 2005 Academy Award-winning film Tsotsi.  Dr Mofokeng studied at Wits Drama School where he initially majored in Acting, and later went on to study at Columbia University in America, where he obtained his master's degree in Theatre Directing.



About the book:
Dr Jerry Mofokeng wa Makhetha always felt like an outsider in his family. At the age of 58, he discovers who his real father is. Suddenly his search for identity makes sense. He gives us a glimpse into his family life – his love for his wife and kids, as well as tracing the highlights and disappointments of his career. Along the way, he learns some very important lessons about manhood. This is a memoir, but also a challenge to South African men to live out their masculinity in a responsible way.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept